Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.70
+0.05 (0.16%)
Jan 22, 2026, 1:35 PM CST

Taiyen Biotech Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
3,2733,2383,4093,6144,0963,130
Upgrade
Revenue Growth (YoY)
1.67%-5.01%-5.67%-11.77%30.84%7.70%
Upgrade
Cost of Revenue
1,9481,9172,1512,3372,7221,823
Upgrade
Gross Profit
1,3261,3211,2571,2771,3731,308
Upgrade
Selling, General & Admin
850.04835.39801.98770.92786.46770.29
Upgrade
Research & Development
56.0754.7160.560.6457.673.98
Upgrade
Operating Expenses
942.97974.38936.04831.56844.06844.27
Upgrade
Operating Income
382.89346.53321.44445.05529.18463.32
Upgrade
Interest Expense
-5.72-6.34-3.35-4.52-5.94-3.61
Upgrade
Interest & Investment Income
30.7537.9335.9317.8810.6615.19
Upgrade
Earnings From Equity Investments
------0.55
Upgrade
Currency Exchange Gain (Loss)
-6.4638.54-5.6758.69-20.59-16.64
Upgrade
Other Non Operating Income (Expenses)
40.7411-21.2620.651.934.92
Upgrade
EBT Excluding Unusual Items
442.21427.66327.1537.74515.23462.62
Upgrade
Gain (Loss) on Sale of Investments
5.0112.857.43-0.36-0.543.17
Upgrade
Gain (Loss) on Sale of Assets
-1.05-1.04-1.28-1.28-1.24-1.76
Upgrade
Other Unusual Items
-23.22-6.44-4.13-5.52-3.54-
Upgrade
Pretax Income
422.94433.03329.12530.59509.92464.04
Upgrade
Income Tax Expense
96.34115.58111.82103.0797.7689.45
Upgrade
Earnings From Continuing Operations
326.61317.45217.3427.52412.16374.59
Upgrade
Minority Interest in Earnings
6.8354.0783.09-0.81-18.94-9.5
Upgrade
Net Income
333.44371.52300.39426.7393.23365.09
Upgrade
Net Income to Common
333.44371.52300.39426.7393.23365.09
Upgrade
Net Income Growth
12.03%23.68%-29.60%8.51%7.71%5.67%
Upgrade
Shares Outstanding (Basic)
200200200200200200
Upgrade
Shares Outstanding (Diluted)
201201200201201201
Upgrade
Shares Change (YoY)
0.08%0.06%-0.08%0.05%-0.02%
Upgrade
EPS (Basic)
1.671.861.502.131.971.83
Upgrade
EPS (Diluted)
1.661.851.502.131.961.82
Upgrade
EPS Growth
12.18%23.33%-29.58%8.67%7.69%5.81%
Upgrade
Free Cash Flow
277.82352.51112.89334.58211.2974.59
Upgrade
Free Cash Flow Per Share
1.391.760.561.671.050.37
Upgrade
Dividend Per Share
1.3001.3001.2001.5001.5001.350
Upgrade
Dividend Growth
8.33%8.33%-20.00%-11.11%-10.00%
Upgrade
Gross Margin
40.50%40.79%36.89%35.33%33.53%41.77%
Upgrade
Operating Margin
11.70%10.70%9.43%12.32%12.92%14.80%
Upgrade
Profit Margin
10.19%11.47%8.81%11.81%9.60%11.66%
Upgrade
Free Cash Flow Margin
8.49%10.89%3.31%9.26%5.16%2.38%
Upgrade
EBITDA
613.12553.56508.88628.74707.81640.44
Upgrade
EBITDA Margin
18.73%17.09%14.93%17.40%17.28%20.46%
Upgrade
D&A For EBITDA
230.23207.03187.44183.69178.64177.12
Upgrade
EBIT
382.89346.53321.44445.05529.18463.32
Upgrade
EBIT Margin
11.70%10.70%9.43%12.32%12.92%14.80%
Upgrade
Effective Tax Rate
22.78%26.69%33.98%19.43%19.17%19.28%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.